VIVLODEX®: The lowest FDA-approved dose of meloxicam available (5 mg)
VIVLODEX is a nonsteroidal anti-inflammatory drug (NSAID) for patients with osteoarthritis pain. Iroko Pharmaceuticals, LLC developed VIVLODEX to align with recommendations from FDA, medical organizations, and advocacy groups: Use the lowest NSAID dose possible for the shortest time needed for your treatment.
Do you know your NSAID dose?
Ask your doctor if you are taking the lowest dose possible for the treatment of OA pain. Then ask about VIVLODEX, the low-dose SoluMatrix® meloxicam from Iroko.
VIVLODEX®: Possible side effects
Before beginning treatment with VIVLODEX, it is important to be aware of potential side effects and to discuss these potential problems with your doctor
The most common side effects reported in clinical studies using VIVLODEX were:
- Abdominal discomfort
VIVLODEX®: Dosing and administration
VIVLODEX is FDA approved at 5-mg and 10-mg doses administered once daily:
- In a clinical study, VIVLODEX helped patients manage osteoarthritis pain at these low doses
- 5 mg is the lowest FDA-approved dose of meloxicam available
- For management of osteoarthritis pain, the recommended starting dosage is 5 mg orally once daily. Dose may be increased to 10 mg in patients who require additional analgesia. The maximum recommended daily oral dose of VIVLODEX is 10 mg